Angus Zoen Lau1,2, Jack Miller2,3, Matthew D Robson1, and Damian J Tyler1,2
1Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom, 2Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, United Kingdom, 3Department of Physics, Clarendon Laboratory, Oxford, United Kingdom
Synopsis
Assessment of cardiac metabolism and perfusion using
hyperpolarized 13C substrates enables discrimination between viable,
hibernating, and non-viable tissue, but current methods require two separate injections
of pre-polarized [1-13C]pyruvate and 13C-urea,
respectively. We propose to use an infusion of co-polarized [1-13C]pyruvate/13C-urea
combined with a flow-sensitized pulse sequence to simultaneously assess both of
these parameters in a single injection. Perfusion and metabolic state are
modulated using specific interventions, and subsequently detected using the new
scan. This probe of both myocardial perfusion and metabolism is anticipated
to enable metabolic study of the heart in acute scenarios.Introduction
The combined
assessment of metabolism and perfusion following acute MI would be useful to
distinguish between viable, hibernating, and non-viable tissue. Current hyperpolarized
13C MRI-based [1] measurements of these parameters require two
separate injections of pre-polarized [1-
13C]pyruvate and
13C-urea, respectively. This lengthens scan time and is infeasible in an acute
setting. In this abstract, we propose to use an infusion of co-polarized [1-
13C]pyruvate
and
13C-urea combined with a flow-sensitized spiral-IDEAL pulse
sequence to simultaneously assess both myocardial metabolism and perfusion in a
single injection.
Methods
Pulse
sequence. Fig. 1
shows the multi-echo ECG-gated spiral pulse sequence used to obtain axial
dynamic images in the heart. Flow contrast [2,3] was incorporated in alternate
frames by inserting a bipolar gradient (m1 = 332 mT·ms2/m, orientation in slice direction) between the
end of the excitation and the start of the readout. The sequence parameters
were: Agilent 7T, 8 echoes + 1 FID, TE0 = 0.8/4.5 ms without/with
flow suppression, ΔTE = 0.5 ms, TR 1 RR, FOV 70x70 mm2, acquired
in-plane res. 1.75x1.75 mm2, thk 5 mm, readout 10 ms, FA 10°. The time
for each set of echoes was 9xRR ≈ 1.5 s.
Co-polarization. [1-13C]pyruvate (14 M) and 13C-urea (6.4 M) were simultaneously polarized with trityl radial (OX63, 15 mM) for
2 hours in a prototype DNP hyperpolarizer[1]. Individual layers were frozen in
liquid nitrogen. Dissolution with 5 mL NaOH/EDTA solution resulted in 2 mL of
pre-polarized 80 mM [1-13C]pyruvate/64 mM urea, transferred to a
magnetic holder (2-10 mT) prior to injection, and injected over 20 seconds via tail vein.
The scan was started prior to injection.
In vivo study. Male Wistar rats (2x2 groups of fed vs.
fasted and rest vs. stress, n=3 each, weight 447±27 g, HR 370±33 bpm) were
scanned supine using a volume Tx birdcage and 2-channel Rx surface array (Rapid
Biomedical). In fed animals, a bolus of the PDK inhibitor dichloroacetate (DCA,
30 mg/kg, pH 7) was injected 10 minutes prior to the 13C infusion. Stress
metabolic and perfusion measurements (n=3) were made under adenosine, a
coronary vasodilator (280 μg/kg/min for 10 min).
Image
reconstruction. Spiral
IDEAL reconstruction was used to transform the multiple echoes to spatial
k-space data corresponding to [1-13C]pyruvate, lactate, alanine,
pyruvate hydrate, 13C bicarbonate, and 13C urea. The
non-Cartesian k-space samples were then converted to an image by NUFFT; images
were Hamming filtered to an in-plane resolution of 2.3x2.3 mm2.
Data
analysis. The heart
was manually segmented using 1H images into right ventricle (RV),
left ventricle (LV), and myocardium. Pyruvate and its downstream metabolic
signals were normalized to the maximum (in time) LV pyruvate signal, and urea
was similarly normalized to maximum LV signal. The AUC for each metabolite was
compared between each condition using two-way ANOVA.
Results and Discussion
Fig. 2 shows
images of [1-13C]pyruvate, lactate, bicarbonate, and urea in the
heart in the four combinations of metabolic and perfusion states. In the frames where the flow-sensitizing
bipolar gradient has been turned on, the bright luminal signal is suppressed,
highlighting the metabolic activity within the myocardium. Modulation of perfusion by adenosine
stress results in increased myocardial pyruvate and urea signal, consistent
with vasodilation. Modulation of metabolic state by feeding and DCA infusion
results in increased myocardial bicarbonate signal relative to fasted tissue. The pyruvate and urea time courses (Fig. 3) appear
very similar, presumably due to the dose of pyruvate being in excess of PDH/LDH
activity in the heart. This supports the use of hyperpolarized 13C-urea
as a perfusion agent, as optimized acquisitions which avoid disturbing the
pyruvate signal reservoir may improve imaging of bicarbonate/lactate under in
states with low PDH/LDH activity. Fig. 4 shows two-way ANOVA results between
each condition, showing that perfusion and metabolic state can be independently
modulated, and subsequently detected using co-polarized 13C-pyruvate/urea.
Future
studies will focus on improving image quality and applications to probe
regional changes in metabolism and perfusion. A proton B0 map [4]
could be incorporated into the reconstruction to correct more severe
off-resonance artifacts such as those in the posterior aspect of the heart. Alternative
excitation schemes [5,6] can be used to take advantage of the additional urea
resonance without disturbing the pyruvate magnetization.
Conclusions
A
flow-sensitized imaging sequence is used to image a co-polarized preparation of
[1-
13C]pyruvate and
13C-urea in the rodent heart,
enabling simultaneous assessment of both metabolism and perfusion. We anticipate
that this strategy will be useful in acute monitoring of metabolic/perfusion
changes during ischemia/reperfusion.
Acknowledgements
National Institute
for Health Research (NIHR) Oxford Biomedical Research Centre Programme
British Heart
Foundation Fellowship (FS/10/002/28078, FS/14/17/30634)
British Heart
Foundation Programme Grant (RG/11/9/28921)
EPSRC Doctoral
Training Centre and Prize Fellowship (EP/M508111/1)
References
[1] Ardenkjaer-Larsen J, et al. Proc Natl
Acad Sci U S A. 2003 Sep 2;100(18):10158-63
[2] Gordon
JW MRM 2015. 10.1002/mrm.25584.
[3] Lau AZ et al. MRM 2015. 10.1002/mrm.25713.
[4] Gordon JW et al. ISMRM 2012.
[5] Chen WC, et al. NMR Biomed 2015;28(8):1021-1030.
[6] Chen AP, et al. JMR
2015;258:81-85.